UNSPSC 51284004: Demeclocycline

This classification denotes a tetracycline antibiotic with the molecular formula C21H21ClN2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5R5W9ICI6O, chemically known as 7-chloro-4-dimethylamino-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide but generally known as demeclocycline, which bears US NIH Compound Identifier 5281009. European Medicines Agency schedules Demeclocycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06963MIG.

UNSPSC 51284004 Demeclocycline is a Commodity code, yet the recent opportunities posted under this code show little alignment with demeclocycline procurement itself. Instead, state and local solicitations tagged to this code are buying pharmaceuticals and medical supplies broadly—including naloxone, generic multi-source drugs and OTC products through cooperative purchasing channels, direct-to-manufacturer prescription programs, and emergency medical consumables for fire rescue operations. The issuing bodies span county health departments, state health and human services commissions, municipal fire departments, and cooperative purchasing alliances serving multiple jurisdictions. Work being solicited includes vendor selection for ongoing pharmaceutical supply agreements with quarterly or annual delivery schedules, competitive bidding for emergency medical kits and supplies with fixed-price contracts, and market-research RFIs to evaluate vendor capacity for direct contracting models outside traditional pharmacy benefit manager arrangements.

Recent activity appears across Florida, Texas, Minnesota, and participating cooperative-purchasing states. Representative opportunities include Seminole County, Florida's IFB (Solicitation IFB60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a two-year initial term; the City of Tampa's sealed-bid solicitation (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division at an estimated $700,000, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent SLBE bid discount; the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802, due March 26, 2026) to establish multi-vendor contracts for generic pharmaceuticals and OTC products distributed across state and local facilities in Minnesota, Oregon, and participating members; and the Texas Health and Human Services Commission's RFI (HHS0017013, posted April 3, 2026) exploring vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional PBM and GPO channels. The code's recent activity suggests pharmaceutical and medical supply procurement focused on volume purchasing, standardized wholesaler distribution networks, and emergency response inventory rather than demeclocycline specifically.